Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: Relationships with markers of tumor hypoxia and microvascularity

Human Pathology

Volumn 44, Issue 3, 2013, Pages 402-411

  Currie, Margaret J ^a   Beardsley, Brooke E ^b   Harris, Gavin C ^b   Gunningham, Sarah P ^a   Dachs, Gabi U ^a   Dijkstra, Birgit ^c   Morrin, Helen R ^a   Wells, J Elisabeth ^a   Robinson, Bridget A ^a,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^c CDHB   (New Zealand)

Author keywords

ALDH1; Breast cancer; CD133; CD44+ CD24 low; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CARBONATE DEHYDRATASE IX; CD133 ANTIGEN; CD24 ANTIGEN; CD31 ANTIGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; PROGESTERONE RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STEM CELL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; MICROVASCULARIZATION; OVERALL SURVIVAL; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; WIDE EXCISION;

ANOXIA; ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICROVESSELS; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; RETINAL DEHYDROGENASE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84873727788     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.004     Document Type: Article

References (35)

1. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells. [Erratum appears in Proc Natl Acad Sci U S A. 2003; 100:6890] Proc Natl Acad Sci USA 100 2003 3983 3988
2. -/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 2005 1154 1159
3. M. Balic, H. Lin, and L. Young Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res 12 2006 5615 5621
4. - phenotype is enriched in basal-like breast tumors Breast Cancer Res 10 2008 R53
5. G. Dontu Breast cancer stem cell markers - the rocky road to clinical applications Breast Cancer Res 10 2008 110
6. - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8 2006 R59
7. C. Ginestier, M.H. Hur, and E. Charafe-Jauffret ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
8. S.Y. Park, H.E. Lee, and H. Li Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer Clin Cancer Res 16 2010 876 887
9. P. Zhao, Y. Lu, X. Jiang, and X. Li Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma Cancer Sci 102 2011 1107 1111
10. N. Castro, C. Osorio, and C. Torres Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma Breast Cancer Res 10 2008 R87
11. V. Espina, and L.A. Liotta What is the malignant nature of human ductal carcinoma in situ? Nat Rev Cancer Cancer 11 2011 68 75
12. M.R. Alison, S.M.L. Lim, and L.J. Nicholson Cancer stem cells: problems for therapy? J Pathol 223 2011 147 161
13. L. Li, and H. Clevers Coexistence of quiescent and active adult stem cells in mammals Science 327 2010 542 545
14. M.C. Brahimi-Horn, J. Chiche, and J. Pouyssegur Hypoxia and cancer J Mol Med 85 2007 1301 1307
15. S.B. Fox, D.G. Generali, and A.L. Harris Breast tumour angiogenesis Breast Cancer Res 9 2007 216
16. J.M. Heddleston, Z. Li, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
17. C. Piccoli, A. D'Aprile, and M. Ripoli The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions FEBS Lett 581 2007 3111 3119
18. C. Calabrese, H. Poppleton, and M. Kocak A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
19. D. Ponti, A. Costa, and N. Zaffaroni Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506 5511
20. H. Morrin, S. Gunningham, and M. Currie The Christchurch Tissue Bank to support cancer research N Z Med J 118 2005 U1735
21. D. Horst, L. Kriegl, J. Engel, T. Kirchner, and A. Jung CD133 expression is an independent prognostic marker for low survival in colorectal cancer Br J Cancer 99 2008 1285 1289
22. K.A. Mackenzie, A.P. Miller, and B.D. Hock Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients Histopathology 58 2011 875 885
23. S.B. Fox, R.D. Leek, and M.P. Weekes Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis J Pathol 177 1995 275 283
24. F. Hillen, A. van de Winkel, D. Creytens, A.H.M. Vermeulen, and A.W. Griffioen Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma Melanoma Res 16 2006 453 457
25. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168
26. A. Bombonati, and D.C. Sgroi The molecular pathology of breast cancer progression J Pathol 223 2011 307 317
27. S. Bao, Q. Wu, and S. Sathornsumetee Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res 66 2006 7843 7848
28. E. Resetkova, J.S. Reis-Filho, and R.K. Jain Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment Breast Cancer Res Treat 123 2010 97 108
29. Q. Liu, J.-G. Li, X.-Y. Zheng, F. Jin, and H.-T. Dong Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas Chin Med J 122 2009 2763 2769
30. G. Storci, P. Sansone, and D. Trere The basal-like breast carcinoma phenotype is regulated by SLUG gene expression J Pathol 214 2008 25 37
31. D.C. Allred, Y. Wu, and S. Mao Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution Clin Cancer Res 14 2008 370 378
32. S.A. Mani, W. Guo, and M.-J. Liao The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
33. X.-J. Ma, S. Dahiya, E. Richardson, M. Erlander, and D.C. Sgroi Gene expression profiling of the tumor microenvironment during breast cancer progression Breast Cancer Res 11 2009 R7
34. G. Finak, N. Bertos, and F. Pepin Stromal gene expression predicts clinical outcome in breast cancer Nat Med 14 2008 518 527
35. S.R. Lakhani, M.J. Van De Vijver, and J. Jacquemier The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2002 2310 2318